Frontlight ResearchEarly access
Active, not recruitingNo phase
Post Market Clinical Follow-up of Dual-mobility Acetabular Cup EUROSCUP MOBILE
Key facts
- Who runs it
- EUROS
- Where
- France3 sites in 1 countryChoose a country to see its sites
- Trial code
- Status
- Active, not recruiting
- People taking part
- 147 people enrolled
- Started
- 1 Jun 2021
- Expected to end
- Jun 2034
- Type of study
- Observational, 2 groups
- Treatments tested
- hip arthroplasty
- Record updated
- 28 August 2024
Who can take part
- Age
- 18 years to 80 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 6 criteriaShow less
Who can take part
- Patient who received EUROSCUP MOBILE
- Patient informed of its participation to the study
- Patient aged between 18 and 80 years old (<80)
Who cannot take part
- Patient presenting a contraindication to EUROSCUP MOBILE implantation
- Patient who refused to participate to the study
- Vulnerable subjects
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
EUROSCUP MOBILE is intended for use in primary and revision total hip replacement surgery.
Read full original descriptionShow less
Hip replacement is intended to provide increased patient mobility and reduce pain by replacing the damages hip joint articulation in patients where there is evidence of sufficient sound bone to seat and support the components.
As part of post market vigilance, EUROS will collect data on EUROSCUP MOBILE performances and safety
The 2 groups in the trial
- EUROSCUP MOBILE cementless
107 who received cementless version of EUROSCUP MOBILE
Treatment: hip arthroplasty
- EUROSCUP MOBILE cemented
40 who received cemented version of EUROSCUP MOBILE
Treatment: hip arthroplasty
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Record updated
- 28 August 2024